| Financial Year |
March 31 2023 |
| Monetary Funds |
953,552,699.70 |
| Held-for-trading Financial Assets |
251,746,575.34 |
| Notes Receivable |
50,758,495.02 |
| Accounts Receivable |
490,502,271.29 |
| Advances to Suppliers |
21,591,532.46 |
| Other Receivables |
953,114.37 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
627,617,633.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
78,672,935.19 |
| Total Current Assets |
3,483,213,639.22 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,395,348,774.86 |
| Under-construction Projects |
1,032,874,672.67 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
229,727,031.38 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
18,689,062.20 |
| Deferred Income Tax Assets |
71,311,946.58 |
| Other Non-Current Assets |
182,405,929.60 |
| Sub-Total of Non-Current Assets |
2,934,468,732.42 |
| Total Assets |
6,417,682,371.64 |
| Short-Term Loans |
30,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
216,591,288.88 |
| Accounts Payable |
224,066,587.75 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
25,633,884.79 |
| Taxes Payable |
57,371,565.91 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
163,692,919.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,062,490.25 |
| Other Current Liabilities |
2,581,136.02 |
| Sub-Total of Current Liabilities |
741,098,582.67 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
914,655.77 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
507,263,931.81 |
| Total Liabilities |
1,248,362,514.48 |
| Paid-In Capital(Or Share Stock) |
518,350,000.00 |
| Capital Surplus |
1,587,393,106.36 |
| Surplus Reserve |
276,685,164.46 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,687,378,448.98 |
| Minority Stockholder's Interest |
106,344,611.16 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,062,975,246.00 |
| Owner's Equity（Stockholder's Equity） |
5,169,319,857.16 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,417,682,371.64 |
